Free Trial

Corvus Pharmaceuticals (CRVS) Insider Trading & Ownership

-0.08 (-3.77%)
(As of 06/14/2024 ET)

Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Amount Of
Insider Buying
(Last 12 Months)
$1.03 M
Number Of
Insiders Selling
(Last 12 Months)
Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRVS Insider Buying and Selling by Quarter

Corvus Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/6/2024Richard A Md MillerCEOBuy577,634$1.73$999,306.82  
5/6/2024William Benton JonesInsiderBuy20,000$1.73$34,600.00  
(Data available from 1/1/2013 forward)

CRVS Insider Trading Activity - Frequently Asked Questions

Who is on Corvus Pharmaceuticals's Insider Roster?

The list of insiders at Corvus Pharmaceuticals includes Ecor1 Capital, Llc, Leiv Lea, Linda Grais, Orbimed Advisors Llc, Richard A Md Miller, and William Benton Jones. Learn more on insiders at CRVS.

What percentage of Corvus Pharmaceuticals stock is owned by insiders?

31.30% of Corvus Pharmaceuticals stock is owned by insiders. Learn more on CRVS's insider holdings.

Which Corvus Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased CRVS shares in the last 24 months: Leiv Lea ($22,200.00), Linda Grais ($24,500.00), Richard A Md Miller ($1,081,656.82), and William Benton Jones ($50,400.00).

How much insider buying is happening at Corvus Pharmaceuticals?

Insiders have purchased a total of 762,634 CRVS shares in the last 24 months for a total of $1,178,756.82 bought.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:CRVS) was last updated on 6/15/2024 by Staff

From Our Partners